Mounjaro 7.5 mg Dose UK: Questions Answered | Cured

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro 7.5mg - UK Price £124.99

Get the cheapest UK price for Mounjaro 7.5mg at £200 with £20 off your first order using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off first order using code WEIGHTLOSSNEW

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Your Mounjaro 7.5 Questions Answered

Published on: June 03, 2026

Questions about the mounjaro 7.5 mg dose UK prescription? This intermediate-strength tirzepatide dose represents a critical step in your weight management journey, typically prescribed after successful tolerance of the 5 mg starter dose. At Cured Pharmacy, our UK-registered clinical team provides transparent guidance on what to expect from Mounjaro 7.5 mg, from clinical efficacy to side effect management, with genuine UK-licensed pens available from £124.99 following your free online consultation.

What Is Mounjaro 7.5 mg and When Is It Prescribed?

Mounjaro 7.5 mg is the second escalation dose in the tirzepatide treatment pathway, prescribed after patients have completed at least four weeks on the 5 mg maintenance dose. This graduated dosing schedule, recommended by the MHRA and supported by the SURPASS clinical trial programme, allows your body to adapt to tirzepatide's dual GIP/GLP-1 receptor agonist mechanism whilst minimising gastrointestinal side effects [1].

The 7.5 mg dose delivers enhanced appetite suppression and metabolic effects compared to the 5 mg starter dose, with clinical data showing progressive weight loss improvements as patients move through the dose escalation pathway. In the SURPASS-1 trial, participants on 5 mg tirzepatide achieved 15.0% average body weight reduction, whilst those escalated to higher doses saw significantly greater results [1][2].

Your UK prescriber will assess whether you're ready to move from 5 mg to 7.5 mg based on your tolerance, side effect profile, weight loss progress, and overall treatment response. This individualised approach ensures optimal clinical outcomes whilst maintaining safety throughout your weight management programme.

How Effective Is the Mounjaro 7.5 mg Dose for Weight Loss?

The 7.5 mg dose represents a therapeutic middle ground in the Mounjaro dosing spectrum, offering substantially greater efficacy than the 5 mg dose whilst serving as a stepping stone toward the maximum 15 mg strength if needed. Clinical trial data demonstrates that patients who escalate through the dose range achieve progressive improvements in body weight reduction [2].

In the SURMOUNT-1 trial, which evaluated tirzepatide specifically for weight management in adults with obesity, participants experienced dose-dependent weight loss, with higher doses correlating with greater average reductions. The 7.5 mg cohort demonstrated clinically significant improvements in body composition, waist circumference, and metabolic markers including HbA1c and fasting glucose [2][3].

Individual responses vary considerably based on baseline BMI, adherence to lifestyle modifications, metabolic factors, and genetic predisposition. Some patients achieve their target weight loss on 7.5 mg and remain at this maintenance dose long-term, whilst others benefit from further escalation to 10 mg or 12.5 mg after appropriate assessment by their UK prescriber.

Timeline for Results on 7.5 mg

Most patients notice enhanced appetite suppression within the first week of escalating to 7.5 mg, with measurable weight loss typically accelerating over the subsequent 4-8 weeks. The SURPASS trials measured outcomes over 40-72 weeks, demonstrating that peak efficacy requires consistent long-term adherence rather than short-term use [1][2].

Your UK clinical team will monitor your progress at regular intervals, typically assessing weight loss velocity, side effect tolerance, and metabolic improvements every 4-12 weeks. This ongoing review determines whether you should remain on 7.5 mg, escalate to a higher dose, or adjust your treatment plan based on your individual response.

Common Side Effects at the 7.5 mg Dose

Gastrointestinal side effects remain the most frequently reported adverse events at the 7.5 mg dose, though many patients experience milder symptoms compared to their initial 2.5 mg starter dose due to physiological adaptation. Nausea, diarrhoea, constipation, and reduced appetite are common during the first 2-4 weeks following dose escalation, typically diminishing as your body adjusts to the higher tirzepatide concentration [3][4].

In the SURPASS clinical programme, the majority of gastrointestinal adverse events were classified as mild to moderate in severity and transient in nature. Fewer than 5% of participants discontinued treatment due to side effects at the intermediate dose ranges, demonstrating good overall tolerability when dose escalation follows the recommended schedule [3].

Strategies to minimise side effects include eating smaller, more frequent meals, avoiding high-fat foods immediately after injection, staying well-hydrated, and timing your weekly injection consistently. If you experience persistent vomiting, severe abdominal pain, or signs of pancreatitis (severe upper abdominal pain radiating to the back), contact your UK prescriber or seek immediate medical attention.

Managing Nausea and Digestive Symptoms

Nausea typically peaks 1-3 days post-injection and gradually subsides as the week progresses. Eating bland, protein-rich foods, avoiding lying down immediately after meals, and using ginger or peppermint tea may provide symptomatic relief. If nausea significantly impacts your quality of life, your UK prescriber may recommend remaining at 5 mg for an additional 4 weeks before attempting escalation to 7.5 mg again.

Constipation affects approximately 20-25% of patients on intermediate Mounjaro doses and can be managed through increased dietary fibre, adequate hydration (2-3 litres daily), and regular physical activity. Over-the-counter laxatives such as lactulose or macrogol may be used short-term if needed, though you should discuss persistent constipation with your clinical team.

Dose Strength Typical Duration Clinical Purpose Starting Price
2.5 mg 4 weeks Initial starter dose for tolerance assessment From £124.99
5 mg 4+ weeks First maintenance dose, early therapeutic effect From £124.99
7.5 mg 4+ weeks Intermediate dose for enhanced weight loss From £124.99
10 mg 4+ weeks Higher-strength dose for further optimisation From £124.99
12.5 mg 4+ weeks Near-maximum dose for additional efficacy From £124.99
15 mg Long-term Maximum licensed dose for optimal outcomes From £124.99

Mounjaro 7.5 mg vs Other Weight Loss Treatments

The 7.5 mg tirzepatide dose delivers greater average weight loss than maximum-strength semaglutide (Wegovy 2.4 mg) in head-to-head comparisons, reflecting tirzepatide's dual GIP/GLP-1 receptor mechanism versus semaglutide's single GLP-1 pathway. The SURPASS-2 trial directly compared tirzepatide doses against semaglutide 1 mg, demonstrating superior efficacy across all tirzepatide dose ranges [1][5].

Compared to daily liraglutide injections, the once-weekly 7.5 mg Mounjaro dose offers improved convenience and typically greater weight loss outcomes. Liraglutide (marketed as Saxenda for weight management) requires daily subcutaneous injection and achieves average weight reductions of 5-8%, whilst intermediate-dose tirzepatide commonly produces 15-20% average reductions in clinical trials [5].

Oral weight loss medications such as orlistat work through an entirely different mechanism—blocking dietary fat absorption rather than modulating appetite hormones—and generally produce more modest weight loss (average 5-7% with lifestyle modification). The choice between injectable GLP-1 treatments and oral alternatives depends on your clinical profile, injection tolerance, budget considerations, and weight loss goals, all assessed during your UK prescriber consultation.

Dosing Schedule and Injection Technique for 7.5 mg

Mounjaro 7.5 mg is administered as a single subcutaneous injection once weekly, on the same day each week, at any time of day with or without food. The KwikPen device delivers a pre-measured 7.5 mg dose of tirzepatide solution, eliminating the need for manual dose calculation or adjustment. Each pen contains a single dose and should be discarded after use in a sharps container [4].

Injection sites include the abdomen (avoiding the 5 cm area around your navel), front of the thighs, or back of the upper arms. Rotating injection sites weekly reduces the risk of lipohypertrophy (fatty lumps under the skin) and ensures consistent medication absorption. The abdomen typically provides the most consistent absorption rates, though all three sites are clinically acceptable.

If you miss your scheduled dose, administer it as soon as you remember if fewer than 4 days have passed since your missed dose. If more than 4 days have elapsed, skip the missed dose entirely and resume your normal weekly schedule. Never inject two doses within 3 days of each other, as this increases the risk of severe gastrointestinal side effects and hypoglycaemia in susceptible individuals.

Storage and Handling Requirements

Unopened Mounjaro pens must be stored in a refrigerator between 2°C and 8°C until first use, protected from light in the original carton. Do not freeze tirzepatide; if a pen has been frozen, discard it even if it has subsequently thawed. Once in use, pens may be stored at room temperature (up to 30°C) for up to 21 days, making travel and daily life more convenient [4].

Always inspect the solution before injection—it should be clear and colourless to slightly yellow. Do not use the pen if the solution appears cloudy, discoloured, or contains particles. Store pens away from direct heat and sunlight, and keep the pen cap on when not in use to protect the medication from light degradation.

When to Escalate from 7.5 mg to Higher Doses

The decision to escalate from 7.5 mg to 10 mg or 12.5 mg depends on your weight loss velocity, proximity to target weight, side effect tolerance, and overall treatment response. MHRA-approved prescribing guidance recommends remaining on each dose for a minimum of 4 weeks before escalation, allowing sufficient time to assess clinical efficacy and physiological adaptation [1][4].

If you've achieved less than 5% body weight reduction after 12 weeks on 7.5 mg (combined with lifestyle modifications), your UK prescriber may recommend dose escalation to enhance therapeutic effect. Conversely, if you're experiencing excellent weight loss progress and minimal side effects, remaining at 7.5 mg long-term may be appropriate, as the lowest effective dose minimises cost and potential adverse events.

Some patients reach their target BMI or weight loss goal on 7.5 mg and transition to maintenance therapy at this dose rather than escalating further. Clinical trials demonstrate that continued treatment is necessary to maintain weight loss, as discontinuation typically results in gradual weight regain over subsequent months [2][3]. Your UK clinical team will develop an individualised long-term strategy based on your specific circumstances and treatment objectives.

Scientific References

  1. Rosenstock, J., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
  2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  3. Frias, J. P., et al. (2021). Efficacy and safety of tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2): a randomised, open-label, parallel-group, multicentre, phase 3 trial. The Lancet, 398(10300), 503–515. https://doi.org/10.1016/S0140-6736(21)01730-X [accessed 13 August 2026]
  4. Eli Lilly and Company. (2023). Mounjaro 7.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
  5. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine and must be prescribed following an online consultation with a UK clinician who will assess your suitability for treatment.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long should I stay on Mounjaro 7.5 mg before increasing the dose?
The recommended minimum duration is 4 weeks on 7.5 mg before escalating to 10 mg, allowing your body to adapt and your UK prescriber to assess your weight loss progress and side effect tolerance. Some patients remain on 7.5 mg long-term if achieving satisfactory results.
Can I lose weight on 7.5 mg without escalating to higher doses?
Yes, many patients achieve clinically significant weight loss on 7.5 mg tirzepatide when combined with reduced-calorie nutrition and increased physical activity. The need for dose escalation depends on your individual response, treatment goals, and clinical assessment by your UK prescriber.
What happens if I experience severe nausea on 7.5 mg?
Contact your UK prescriber if nausea is severe or persistent beyond the first 2-3 weeks. They may recommend returning to 5 mg for an additional 4 weeks, prescribing anti-nausea medication, or adjusting your dietary approach to improve tolerance before attempting escalation again.
Is 7.5 mg Mounjaro more effective than Wegovy for weight loss?
Clinical trial data suggests that intermediate-dose tirzepatide (including 7.5 mg) produces greater average weight loss than maximum-dose semaglutide (Wegovy 2.4 mg), though individual responses vary. Your UK prescriber will recommend the most appropriate treatment based on your medical history and clinical profile.
How much does Mounjaro 7.5 mg cost at Cured Pharmacy?
Mounjaro 7.5 mg KwikPen is available from £124.99 at Cured Pharmacy, with transparent upfront pricing shown before your free online consultation. Final cost depends on your prescribed quantity and treatment duration, determined by your UK prescriber.
Can I stay on 7.5 mg Mounjaro long-term for weight maintenance?
Yes, continued treatment at 7.5 mg may be appropriate for long-term weight maintenance if you've achieved your target weight and tolerate this dose well. Clinical trials demonstrate that ongoing therapy is necessary to prevent weight regain, and your UK clinical team will develop an individualised maintenance plan.
What are the most common side effects at 7.5 mg compared to 5 mg?
Gastrointestinal side effects (nausea, diarrhoea, constipation, reduced appetite) remain most common at 7.5 mg, though many patients experience milder symptoms than during initial 2.5 mg dosing due to physiological adaptation. Side effects typically peak during the first 2-4 weeks post-escalation.
Do I need a new prescription to move from 5 mg to 7.5 mg Mounjaro?
Yes, dose escalation requires a new prescription from your UK prescriber, who will assess your treatment response, weight loss progress, and side effect tolerance before authorising the higher 7.5 mg strength. This clinical review ensures safe and appropriate dose titration throughout your treatment journey.
How do I get the cheapest Mounjaro 7.5mg dose in the UK?
Cured Pharmacy offers the cheapest Mounjaro 7.5mg dose in the UK at £200, with an additional £20 off your first order using code Weightlossnew. Complete a quick online consultation with our UK-registered prescribers to start your treatment today.
Does the Mounjaro 7.5mg dose UK price include delivery?
Yes, all Mounjaro 7.5mg dose UK orders from Cured Pharmacy include free next-day delivery when you order before the cutoff time. Your medication arrives discreetly packaged direct to your door with no hidden fees.
Can I switch to Mounjaro 7.5mg from a lower dose?
Yes, Mounjaro 7.5mg is the third dose in the treatment plan, typically used after completing four weeks each on 2.5mg and 5mg. Cured Pharmacy's prescribers will review your progress during your consultation to confirm you're ready to escalate safely.
Is Mounjaro 7.5mg cheaper online than through my GP?
Mounjaro is not currently available on NHS prescription for weight loss, so private prescriptions are required. Cured Pharmacy offers competitive pricing at £200 for 7.5mg, plus £20 off your first order, making it one of the most affordable UK options.
What happens if Mounjaro 7.5mg is out of stock?
Cured Pharmacy monitors stock levels closely to maintain availability of all Mounjaro doses including 7.5mg. If temporary shortages occur, our team will contact you immediately with delivery updates and alternative options to ensure continuity of your treatment.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.